Search Results

Filter
  • 1-10 of  1,027 results for ""Antibodies, Neutralizing""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Absolute concentration estimation of COVID-19 convalescent and post-vaccination IgG antibodies.

  • Authors : Klegerman ME; Department of Internal Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, United States of America.; Peng T

Subjects: COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Immunoglobulin G*/Immunoglobulin G*/Immunoglobulin G*/immunology

  • Source: PloS one [PLoS One] 2024 Nov 01; Vol. 19 (11), pp. e0311777. Date of Electronic Publication: 2024 Nov 01 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Predicting neutralization susceptibility to combination HIV-1 monoclonal broadly neutralizing antibody regimens.

  • Authors : Williamson BD; Biostatistics Division, Kaiser Permanente Washington Health Research Institute, Seattle, WA, United States of Amerrica.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States of Amerrica.

Subjects: HIV-1*/HIV-1*/HIV-1*/immunology ; HIV-1*/HIV-1*/HIV-1*/drug effects ; Antibodies, Neutralizing*/Antibodies, Neutralizing*/Antibodies, Neutralizing*/immunology

  • Source: PloS one [PLoS One] 2024 Sep 06; Vol. 19 (9), pp. e0310042. Date of Electronic Publication: 2024 Sep 06 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Neutralizing antibody against GDF15 for treatment of cancer-associated cachexia.

  • Authors : Xiong J; College of Pharmacy, Xinjiang Medical University, Urumqi, Xinjiang, China.; Wu G

Subjects: Growth Differentiation Factor 15* ; Cachexia*/Cachexia*/Cachexia*/drug therapy ; Cachexia*/Cachexia*/Cachexia*/immunology

  • Source: PloS one [PLoS One] 2024 Aug 22; Vol. 19 (8), pp. e0309394. Date of Electronic Publication: 2024 Aug 22 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Anti-hemagglutinin monomeric nanobody provides prophylactic immunity against H1 subtype influenza A viruses.

  • Authors : Barbieri ES; Virology Institute IncuINTA (IVIT-CONICET), National Institute of Agricultural Technology, Hurlingham, Buenos Aires, Argentina.; National Council for Scientific and Technical Research (CONICET), Buenos Aires City, Buenos Aires, Argentina.

Subjects: Hemagglutinin Glycoproteins, Influenza Virus*/Hemagglutinin Glycoproteins, Influenza Virus*/Hemagglutinin Glycoproteins, Influenza Virus*/immunology ; Influenza A Virus, H1N1 Subtype*/Influenza A Virus, H1N1 Subtype*/Influenza A Virus, H1N1 Subtype*/immunology ; Single-Domain Antibodies*/Single-Domain Antibodies*/Single-Domain Antibodies*/immunology

  • Source: PloS one [PLoS One] 2024 Jul 10; Vol. 19 (7), pp. e0301664. Date of Electronic Publication: 2024 Jul 10 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Differential laboratory passaging of SARS-CoV-2 viral stocks impacts the in vitro assessment of neutralizing antibodies.

  • Authors : Avila-Herrera A; Lawrence Livermore National Laboratory, Computing Directorate, Global Security Computing Applications Division, Livermore, California, United States of America.; Kimbrel JA

Subjects: Antibodies, Neutralizing* ; COVID-19*; Humans

  • Source: PloS one [PLoS One] 2024 Jan 25; Vol. 19 (1), pp. e0289198. Date of Electronic Publication: 2024 Jan 25 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Performance evaluation of the Roche Elecsys® Anti-SARS-CoV-2 immunoassays by comparison with neutralizing antibodies and clinical assessment.

  • Authors : Takei S; Department of Clinical Laboratory, Juntendo University Hospital, Tokyo, Japan.; Department of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Subjects: Antibodies, Neutralizing* ; COVID-19*/COVID-19*/COVID-19*/diagnosis; Antibodies, Viral

  • Source: PloS one [PLoS One] 2022 Sep 15; Vol. 17 (9), pp. e0274181. Date of Electronic Publication: 2022 Sep 15 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Enhancing neutralizing activity against influenza H1N1/PR8 by engineering a single-domain VL-M2 specific into a bivalent form.

  • Authors : Hoang PT; Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, Republic of Korea.; Luong QXT

Subjects: Antibodies, Neutralizing* ; Influenza A Virus, H1N1 Subtype* ; Influenza, Human*/Influenza, Human*/Influenza, Human*/prevention & control

  • Source: PloS one [PLoS One] 2022 Aug 31; Vol. 17 (8), pp. e0273934. Date of Electronic Publication: 2022 Aug 31 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

The IgA in milk induced by SARS-CoV-2 infection is comprised of mainly secretory antibody that is neutralizing and highly durable over time.

  • Authors : Fox A; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.; Marino J

Subjects: Antibodies, Neutralizing/Antibodies, Neutralizing/Antibodies, Neutralizing/*immunology ; Immunoglobulin A/Immunoglobulin A/Immunoglobulin A/*immunology ; Milk, Human/Milk, Human/Milk, Human/*metabolism

  • Source: PloS one [PLoS One] 2022 Mar 09; Vol. 17 (3), pp. e0249723. Date of Electronic Publication: 2022 Mar 09 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Poor neutralization and rapid decay of antibodies to SARS-CoV-2 variants in vaccinated dialysis patients.

  • Authors : Bassi J; Humabs BioMed SA, A Subsidiary of Vir Biotechnology, Bellinzona, Switzerland.; Giannini O

Subjects: Neutralization Tests* ; Renal Dialysis* ; Vaccination*SARS-CoV-2 variants

  • Source: PloS one [PLoS One] 2022 Feb 10; Vol. 17 (2), pp. e0263328. Date of Electronic Publication: 2022 Feb 10 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

FluoRNT: A robust, efficient assay for the detection of neutralising antibodies against yellow fever virus 17D.

  • Authors : Scheck MK; Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany.; Lehmann L

Subjects: Antibodies, Neutralizing/Antibodies, Neutralizing/Antibodies, Neutralizing/*immunology ; Yellow Fever/Yellow Fever/Yellow Fever/*immunology ; Yellow fever virus/Yellow fever virus/Yellow fever virus/*immunology

  • Source: PloS one [PLoS One] 2022 Feb 09; Vol. 17 (2), pp. e0262149. Date of Electronic Publication: 2022 Feb 09 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
  • 1-10 of  1,027 results for ""Antibodies, Neutralizing""